Monthly Archives: October 2017
Use of Probiotics in Hospitalized Adults to Prevent Clostridium difficile Infection: DownGRADE the Quality of Evidence?
We read the paper by Shen et al with interest.1 The authors demonstrated, in a meta-analysis of randomized controlled trials (RCTs), a significant effect of probiotics in terms of preventing Clostridium difficile infection in hospitalized adults takin… Continue reading
Fatty mesenteric lymphadenopathy: what does it mean?”
Association Between Screen-detected Gallstone Disease and Cancer in a Cohort Study
I read with great interest the report of Shabanzadeh et al.1 In a cohort study, they found that around 10% of participants had screen-detected gallstone disease, gallstones, and cholecystectomy. Subjects with gallstone disease had a significantly high… Continue reading
A Case of Unusual Ileal Discolouration
Metroticket 2.0 Model for Analysis of Competing Risks of Death Following Liver Transplantation for Hepatocellular Carcinoma
Outcomes of liver transplantation for hepatocellular carcinoma (HCC) are determined by cancer-related and non-related events. Treatments for hepatitis C virus (HCV) infection have reduced non-cancer events among patients receiving liver transplants, so… Continue reading
A rare Submucosal Tumor of The Colon
Exam 1: A Large Retroperitoneal Mass in an Asymptomatic 22-Year-Old Man
Reply
We have explored associations for screen-detected gallstone disease and cancer in a Danish general population cohort and identified associations for gallstone disease and incident gastrointestinal cancer, especially for right-side colon cancer.1 Based … Continue reading
Esophageal Dilation in Eosinophilic Esophagitis: Not Just for Adults Anymore
Reply
Viggars et al offer 3 reasons why they believe the results of our systematic review with meta-analysis assessing probiotic efficacy for prevention of Clostridium difficile infection should be downgraded from high to low or possibly very low quality of… Continue reading